These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


285 related items for PubMed ID: 12097276

  • 1. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.
    LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS.
    Cancer Res; 2002 Jul 01; 62(13):3691-7. PubMed ID: 12097276
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
    Vijayanathan V, Venkiteswaran S, Nair SK, Verma A, Thomas TJ, Zhu BT, Thomas T.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2038-48. PubMed ID: 16609013
    [Abstract] [Full Text] [Related]

  • 4. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ, Zhu BT.
    J Steroid Biochem Mol Biol; 2004 Mar 01; 88(3):265-75. PubMed ID: 15120420
    [Abstract] [Full Text] [Related]

  • 5. 2-Methoxyestradiol, an endogenous metabolite of estrogen, enhances apoptosis and beta-galactosidase expression in vascular endothelial cells.
    Tsukamoto A, Kaneko Y, Yoshida T, Han K, Ichinose M, Kimura S.
    Biochem Biophys Res Commun; 1998 Jul 09; 248(1):9-12. PubMed ID: 9675076
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 09; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 9. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
    Hall JM, Korach KS.
    Mol Endocrinol; 2003 May 09; 17(5):792-803. PubMed ID: 12586845
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemotherapy of breast cancer-additive anticancerogenic effects by 2-methoxyestradiol?
    Mueck AO, Seeger H, Huober J.
    Life Sci; 2004 Jul 23; 75(10):1205-10. PubMed ID: 15219808
    [Abstract] [Full Text] [Related]

  • 13. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
    Yamamoto Y, Shibata J, Yonekura K, Sato K, Hashimoto A, Aoyagi Y, Wierzba K, Yano S, Asao T, Buzdar AU, Terada T.
    Clin Cancer Res; 2005 Jan 01; 11(1):315-22. PubMed ID: 15671561
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 17Beta-estradiol up-regulates vascular endothelial growth factor receptor-2 expression in human myometrial microvascular endothelial cells: role of estrogen receptor-alpha and -beta.
    Gargett CE, Zaitseva M, Bucak K, Chu S, Fuller PJ, Rogers PA.
    J Clin Endocrinol Metab; 2002 Sep 01; 87(9):4341-9. PubMed ID: 12213896
    [Abstract] [Full Text] [Related]

  • 16. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation.
    Pozo-Guisado E, Lorenzo-Benayas MJ, Fernández-Salguero PM.
    Int J Cancer; 2004 Mar 20; 109(2):167-73. PubMed ID: 14750165
    [Abstract] [Full Text] [Related]

  • 17. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
    Rajah TT, Du N, Drews N, Cohn R.
    Pharmacology; 2009 Mar 20; 84(2):68-73. PubMed ID: 19556829
    [Abstract] [Full Text] [Related]

  • 18. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA, Lee MK, Nam KH, Chung WY, Park CS, Lee JH, Noh T, Yang WI, Rhee Y, Lim SK, Lee HC, Lee EJ.
    J Endocrinol; 2007 Nov 20; 195(2):255-63. PubMed ID: 17951536
    [Abstract] [Full Text] [Related]

  • 19. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
    Masuda H, Otsuka F, Matsumoto Y, Takano M, Miyoshi T, Inagaki K, Shien T, Taira N, Makino H, Doihara H.
    Mol Cell Endocrinol; 2011 Aug 22; 343(1-2):7-17. PubMed ID: 21664418
    [Abstract] [Full Text] [Related]

  • 20. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
    Wilson VS, Bobseine K, Gray LE.
    Toxicol Sci; 2004 Sep 22; 81(1):69-77. PubMed ID: 15166400
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.